Journal article
1893P Immune-related adverse events from contemporary first-line combination therapies in metastatic renal cell carcinoma: Results from the IMDC
Authors
Navani V; Lemelin A; Powles TB; Liow ECH; Wong SSL; Meza LA; Ebrahimi H; Saliby RM; Saad E; Yuasa T
Journal
Annals of Oncology, Vol. 34, , pp. s1018–s1019
Publisher
Elsevier
Publication Date
10 2023
DOI
10.1016/j.annonc.2023.09.1123
ISSN
0923-7534